A Study of Selumetinib in Patients With Kaposi's Sarcoma (SCART)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Sheffield Teaching Hospitals NHS Foundation Trust
Sponsor:
Collaborators:
Cancer Research UK Clinical Trials Unit, Birmingham UK
AstraZeneca
Thermo Fisher Scientific
Cancer Research UK
University of Sheffield
Information provided by (Responsible Party):
Sheffield Teaching Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01752569
First received: August 17, 2012
Last updated: September 18, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)